Charles Russell Speechlys advise Apposite Capital on investment into OrthoD Group

Charles Russell Speechlys have advised new client Apposite Capital, the private equity firm with an exclusive focus on healthcare, on the acquisition of OrthoD Group from The Riverside Company.
 
OrthoD is a specialist manufacturer and distributor of medical products and implants for joint reconstruction, sport medicine, surgical products and infection control applications. Created in 1984, OrthoD is a UK based provider of specialist solutions for orthopaedic surgery. The company’s products range from bone cement management systems, wound drainage, fixation devices for knee and shoulder surgery and other specialist devices. The company has distribution channels in over 40 countries worldwide and employs over 100 people.
 
Apposite Capital sees significant potential in supporting management in further building OrthoD’s export channels and in further commercialising OrthoD’s sport medicine products.
 
Rory Pope, Partner, Apposite Capital who is also joining the board of OrthoD, said: “Medical devices companies are a key focus to Apposite and a sector where we have had excellent outcomes. We are delighted to support this MBO; OrthoD is a solid business which has built a strong reputation with its customers and we look forward supporting Daniel and the rest of the team to accelerate their growth ambitions for the business. A great job yet again from Malcolm, Richard and the whole Charles Russell Speechlys team, thank you for the great effort!”
 
Malcolm MacDougall, Corporate Partner, commented: “ We were delighted to work with Rory and the Apposite Capital team on our first transaction for them. OrthoD is an exciting and innovative business in the Healthcare space, tying in with what is one of our core focus areas. We look forward to working closely with the team in the future”.
 
The Charles Russell Speechlys core team included Malcolm MacDougall. Richard Coleman, Rajiv Kakkad, Hannah Dawson and Alice Mason.